These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32983140)

  • 21. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
    Petlickovski A; Laurenti L; Li X; Marietti S; Chiusolo P; Sica S; Leone G; Efremov DG
    Blood; 2005 Jun; 105(12):4820-7. PubMed ID: 15728130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular characterization of neoplastic and normal "sister" lymphoblastoid B-cell lines from chronic lymphocytic leukemia.
    Lanemo Myhrinder A; Hellqvist E; Bergh AC; Jansson M; Nilsson K; Hultman P; Jonasson J; Buhl AM; Bredo Pedersen L; Jurlander J; Klein E; Weit N; Herling M; Rosenquist R; Rosén A
    Leuk Lymphoma; 2013 Aug; 54(8):1769-79. PubMed ID: 23297799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of a poor prognostic chronic lymphocytic leukemia-like disease model: PKCα subversion induces up-regulation of PKCβII expression in B lymphocytes.
    Nakagawa R; Vukovic M; Tarafdar A; Cosimo E; Dunn K; McCaig AM; Holroyd A; McClanahan F; Ramsay AG; Gribben JG; Michie AM
    Haematologica; 2015 Apr; 100(4):499-510. PubMed ID: 25616575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The meaning and relevance of B-cell receptor structure and function in chronic lymphocytic leukemia.
    Stevenson FK; Forconi F; Packham G
    Semin Hematol; 2014 Jul; 51(3):158-67. PubMed ID: 25048780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic variation of CD5 surface expression levels within individual chronic lymphocytic leukemia clones.
    Bashford-Rogers RJ; Palser AL; Hodkinson C; Baxter J; Follows GA; Vassiliou GS; Kellam P
    Exp Hematol; 2017 Feb; 46():31-37.e10. PubMed ID: 27693386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the mRNA expression profile of B-cell receptor components in normal CD5-high B-lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70.
    Gladkikh AA; Potashnikova DM; Tatarskiy V; Yastrebova M; Khamidullina A; Barteneva N; Vorobjev I
    Cancer Med; 2017 Dec; 6(12):2984-2997. PubMed ID: 29125235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different clonal origin of B-cell populations of chronic lymphocytic leukemia and large-cell lymphoma in Richter's syndrome.
    Matolcsy A; Casali P; Knowles DM
    Ann N Y Acad Sci; 1995 Sep; 764():496-503. PubMed ID: 7486574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The inhibitory receptor Siglec-G controls the severity of chronic lymphocytic leukemia.
    Röder B; Fahnenstiel H; Schäfer S; Budeus B; Dampmann M; Eichhorn M; Angermüller S; Brost C; Winkler TH; Seifert M; Nitschke L
    EMBO Rep; 2023 Aug; 24(8):e56420. PubMed ID: 37424400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells.
    Dal Bo M; D'Agaro T; Gobessi S; Zucchetto A; Dereani S; Rossi D; Zaja F; Pozzato G; Di Raimondo F; Gaidano G; Laurenti L; Del Poeta G; Efremov DG; Gattei V; Bomben R
    Oncotarget; 2015 Aug; 6(22):19102-17. PubMed ID: 26036258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia.
    Papakonstantinou N; Ntoufa S; Tsagiopoulou M; Moysiadis T; Bhoi S; Malousi A; Psomopoulos F; Mansouri L; Laidou S; Papazoglou D; Gounari M; Pasentsis K; Plevova K; Kuci-Emruli V; Duran-Ferrer M; Davis Z; Ek S; Rossi D; Gaidano G; Ritgen M; Oscier D; Stavroyianni N; Pospisilova S; Davi F; Ghia P; Hadzidimitriou A; Belessi C; Martin-Subero JI; Pott C; Rosenquist R; Stamatopoulos K
    Int J Cancer; 2019 Jun; 144(11):2695-2706. PubMed ID: 30447004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B Cell Anergy Modulated by TLR1/2 and the miR-17∼92 Cluster Underlies the Indolent Clinical Course of Chronic Lymphocytic Leukemia Stereotyped Subset #4.
    Ntoufa S; Papakonstantinou N; Apollonio B; Gounari M; Galigalidou C; Fonte E; Anagnostopoulos A; Belessi C; Muzio M; Ghia P; Stamatopoulos K
    J Immunol; 2016 May; 196(10):4410-7. PubMed ID: 27059597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SLP76 integrates into the B-cell receptor signaling cascade in chronic lymphocytic leukemia cells and is associated with an aggressive disease course.
    Dezorella N; Katz BZ; Shapiro M; Polliack A; Perry C; Herishanu Y
    Haematologica; 2016 Dec; 101(12):1553-1562. PubMed ID: 27443285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cultured malignant B-1 line serves as a model for Richter's syndrome.
    Peng B; Sherr DH; Mahboudi F; Hardin J; Wu YH; Sharer L; Raveché ES
    J Immunol; 1994 Aug; 153(4):1869-80. PubMed ID: 8046247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias.
    Golay J; Luppi M; Songia S; Palvarini C; Lombardi L; Aiello A; Delia D; Lam K; Crawford DH; Biondi A; Barbui T; Rambaldi A; Introna M
    Blood; 1996 Mar; 87(5):1900-11. PubMed ID: 8634438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosis.
    Del Giudice I; Chiaretti S; Santangelo S; Tavolaro S; Peragine N; Marinelli M; Ilari C; Raponi S; Messina M; Nanni M; Mauro FR; Piciocchi A; Bontempi K; Rossi D; Gaidano G; Guarini A; Foà R
    Am J Hematol; 2014 Jan; 89(1):74-82. PubMed ID: 24030933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of functional sphingosine-1 phosphate receptor-1 is reduced by B cell receptor signaling and increased by inhibition of PI3 kinase δ but not SYK or BTK in chronic lymphocytic leukemia cells.
    Till KJ; Pettitt AR; Slupsky JR
    J Immunol; 2015 Mar; 194(5):2439-46. PubMed ID: 25632006
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Iyer P; Zhang B; Liu T; Jin M; Hart K; Zhang J; Siegert V; Remke M; Wang X; Yu L; Song J; Venkataraman G; Chan WC; Jia Z; Buchner M; Siddiqi T; Rosen ST; Danilov A; Wang L
    Sci Transl Med; 2024 Jul; 16(758):eadg7915. PubMed ID: 39083585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia.
    Minici C; Gounari M; Übelhart R; Scarfò L; Dühren-von Minden M; Schneider D; Tasdogan A; Alkhatib A; Agathangelidis A; Ntoufa S; Chiorazzi N; Jumaa H; Stamatopoulos K; Ghia P; Degano M
    Nat Commun; 2017 Jun; 8():15746. PubMed ID: 28598442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor.
    Chiorazzi N; Ferrarini M
    Annu Rev Immunol; 2003; 21():841-94. PubMed ID: 12615894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1.
    Kohlhaas V; Blakemore SJ; Al-Maarri M; Nickel N; Pal M; Roth A; Hövelmeyer N; Schäfer SC; Knittel G; Lohneis P; Nikolic M; Wiederstein JL; Franitza M; Georgomonolis T; Reinart N; Herling M; Herling C; Hartmann EM; Rosenwald A; Klapper W; Büttner R; Moia R; Rossi D; Boldorini R; Gaidano G; Frenzel LP; Reinhardt HC; Brüning JC; Hallek M; Krüger M; Peifer M; Pallasch CP; Wunderlich FT
    Blood; 2021 Feb; 137(5):646-660. PubMed ID: 33538798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.